EP3953387
COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.4.2020EP published:
3.7.2024EP application number:
20719739.3
EPO information:
European Patent Register
Max expiry date:
8.4.2040
Title in English:
COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITORLanguage of the patent:
English
Timeline
Today
9.4.2020EP application
3.7.2024EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property Development LtdAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Name:
Springworks Therapeutics, Inc.Address:
100 Washington Blvd. 5th Floor, Stamford, CT 06902, US
Inventor
Name:
BISWAS, SwethajitAddress:
Collegeville, Pennsylvania 19426, US
Name:
HOLKOVA, BeataAddress:
Collegeville, Pennsylvania 19426, US
Name:
LUPTAKOVA, KatarinaAddress:
Collegeville, Pennsylvania 19426, US
Priority
Number:
201962831913 PDate:
10.4.2019Country:
US
Number:
201962943480 PDate:
4.12.2019Country:
US
Classification
Categories:
C07K 16/28, A61P 35/02, A61K 47/68, A61K 39/00